A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
Status:
Active, not recruiting
Trial end date:
2022-07-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in
participants with advanced solid tumors where the efficacy of PD-1 inhibitors has previously
been established.